Short Interest in 111, Inc. Sponsored ADR (NASDAQ:YI) Drops By 57.5%

111, Inc. Sponsored ADR (NASDAQ:YI) was the recipient of a significant decline in short interest in May. As of May 29th, there was short interest totaling 6,011 shares, a decline of 57.5% from the May 14th total of 14,127 shares. Based on an average trading volume of 21,907 shares, the days-to-cover ratio is presently 0.3 days. Approximately 0.1% of the shares of the stock are short sold.

111 Trading Down 1.8%

NASDAQ YI opened at $4.28 on Friday. The stock’s 50-day moving average price is $5.95 and its two-hundred day moving average price is $5.64. The company has a market cap of $37.62 million, a PE ratio of -3.06 and a beta of 0.60. 111 has a 1 year low of $2.48 and a 1 year high of $11.17.

Insider Buying and Selling

In other 111 news, Director Jian David Sun sold 115,440 shares of the business’s stock in a transaction dated Wednesday, June 10th. The shares were sold at an average price of $0.22, for a total value of $25,396.80. Following the sale, the director directly owned 583,111 shares in the company, valued at approximately $128,284.42. The trade was a 16.53% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Insiders have sold 331,720 shares of company stock valued at $80,427 in the last quarter. 43.90% of the stock is currently owned by insiders.

Analysts Set New Price Targets

Separately, Weiss Ratings cut shares of 111 from a “sell (d-)” rating to a “sell (e+)” rating in a research report on Thursday, June 4th. One equities research analyst has rated the stock with a Sell rating, Based on data from MarketBeat, the stock has a consensus rating of “Sell”.

111 Company Profile

111, Inc (NASDAQ: YI) is a leading online pharmacy e-commerce platform in China, operating under the brand 111.com. The company provides consumers with a comprehensive selection of pharmaceutical and healthcare products through its proprietary digital channels, including a website and mobile applications. By integrating online ordering, prescription management, and direct-to-consumer delivery, 111, Inc aims to streamline the purchase of medicines and health-related goods for customers nationwide.

111, Inc’s product portfolio encompasses prescription and over-the-counter drugs, nutritional supplements, vitamins, maternal and child care items, personal care products, and beauty goods.